A recent FiercePharma article discussed a conundrum Roche faces with one of their non-operating plants. Back in 2015, the pharmaceutical company decided to close four small-molecule plants around the world. The company sold three of them, but couldn’t find a buyer for the one in Clarecastle, Ireland. So, the company has decided to roll in the breaking balls, and demolish the site. But with 10 buildings on an 88-acre site, that’s no easy task.
What Will Roche Do With an Unsellable Irish Plant?
Roche closed four manufacturing plants in 2015. Three of them sold, but what’s the plan for the fourth?
Mar 12, 2021
Recommended
Recommended
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
